DMI ACQUISITION CORP has a total of 32 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Canada, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals, packaging and shipping and machines are ZYSIS LTD, NATUMIN PHARMA AB and SHANGHAI INST OF CYTOBIOLOGY C.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Brazil | 3 | |
#4 | China | 3 | |
#5 | Singapore | 3 | |
#6 | United States | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Republic of Korea | 2 | |
#9 | Mexico | 2 | |
#10 | Colombia | 1 | |
#11 | Hong Kong | 1 | |
#12 | New Zealand | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Packaging and shipping | |
#3 | Machines | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Containers for goods storage | |
#4 | Unspecified technologies | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bar-Or David | 26 |
#2 | David Bar-Or | 3 |
#3 | Bar Or David | 2 |
#4 | David Bor-Or | 1 |
#5 | Bar-Or Raphael | 1 |
#6 | Shimonkevitz Richard | 1 |
Publication | Filing date | Title |
---|---|---|
CA2810844A1 | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions | |
BRPI1010086A2 | disease treatment method and products | |
CN106109475A | The Therapeutic Method of disease |